Apalutamide will decrease the level or outcome of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Coadministration of apalutamide, a powerful CYP3A4 inducer, with medicine which can be CYP3A4 substrates may lead to lower exposure to those medicines. Do not skip tablets Even when https://beckettkbnbe.dsiblogger.com/63050319/wymzya-fe-birth-control-options